TG-C
Phase 3Cell and gene therapy for osteoarthritis; the first US phase 3 results came in July.
FROM PUBLIC EVENTS · 2026-11-15
Late clinical · capacity The affiliate's osteoarthritis therapy released its first US phase 3 results.
Roles often seen at this stageClinical & PV · Regulatory affairs · Research & development
A company in medicines, pharmaceutical ingredients and biologics; an affiliate is running US Phase 3 trials of the osteoarthritis cell and gene therapy TG-C.
Cell and gene therapy for osteoarthritis; the first US phase 3 results came in July.
The affiliate announced the first US Phase 3 results for TG-C.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.